BE662507A - - Google Patents

Info

Publication number
BE662507A
BE662507A BE662507DA BE662507A BE 662507 A BE662507 A BE 662507A BE 662507D A BE662507D A BE 662507DA BE 662507 A BE662507 A BE 662507A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE662507A publication Critical patent/BE662507A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE662507D 1963-12-23 1965-04-14 BE662507A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US332901A US3240780A (en) 1963-12-23 1963-12-23 Amino-pyrazinoyl guanidines

Publications (1)

Publication Number Publication Date
BE662507A true BE662507A (fr) 1965-10-14

Family

ID=23300353

Family Applications (1)

Application Number Title Priority Date Filing Date
BE662507D BE662507A (fr) 1963-12-23 1965-04-14

Country Status (3)

Country Link
US (1) US3240780A (fr)
BE (1) BE662507A (fr)
GB (1) GB1095792A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008156174A1 (fr) 2007-06-21 2008-12-24 Taisho Pharmaceutical Co., Ltd. Composé de pyrazinamide

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6409716A (fr) * 1962-10-30 1965-10-01
US3472848A (en) * 1966-11-17 1969-10-14 Merck & Co Inc 3-hydroxy and 3-mercapto-pyrazinoyl-guanidines,corresponding ethers and thioethers and processes for their preparation
US3954753A (en) * 1974-02-01 1976-05-04 Hoffmann-La Roche Inc. 2-Aroyl-3-amino pyrazines and the 3(-2haloacetamide derivatives thereof
US4208413A (en) * 1977-03-04 1980-06-17 Merck & Co., Inc. N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same
US4115573A (en) * 1977-03-04 1978-09-19 Merck & Co., Inc. N-pyrazinecarbonyl-N'-substituted-sulfamoylguanidine and processes for preparing same
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
DE3275160D1 (en) * 1982-01-04 1987-02-26 Karl H Beyer Hyperuretic agents
US4894376A (en) * 1988-02-26 1990-01-16 Trustees Of The University Of Pennsylvania Methods of treating diseases characterized by hyperexcitability of neurons
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
AU2013363218B2 (en) 2012-12-17 2018-03-15 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
KR20150095870A (ko) 2012-12-17 2015-08-21 패리온 사이언스 인코퍼레이티드 3,5-디아미노-6-클로로-n-(n-(4-페닐부틸)카르밤이미도일)피라진-2-카르복스아미드 화합물
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008156174A1 (fr) 2007-06-21 2008-12-24 Taisho Pharmaceutical Co., Ltd. Composé de pyrazinamide

Also Published As

Publication number Publication date
US3240780A (en) 1966-03-15
GB1095792A (en) 1967-12-20

Similar Documents

Publication Publication Date Title
BE627012A (fr)
BE627025A (fr)
BE644649A (fr)
BE626803A (fr)
BE626826A (fr)
BE626358A (fr)
BE625880A (fr)
BE625828A (fr)
BE625825A (fr)
BE625136A (fr)
BE624982A (fr)
BE624811A (fr)
BE624070A (fr)
BE623490A (fr)
BE623315A (fr)
BE623220A (fr)
BE623162A (fr)
BE623117A (fr)
BE662507A (fr)
BE622160A (fr)
BE627141A (fr)
BE645361A (fr)
BE645222A (fr)
BE645037A (fr)
BE644850A (fr)